What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet
Himanshu Kakkar - May 23, 2020
The Outperformers (41-50)
These companies have been ranked based on their stock's excess return over the Sensex for a five-year period
August 28, 2019
Minimising Pain
Perfint is on its way to revolutionise cancer care in India and around the world
Kripa Mahalingam - August 25, 2016
Self-healing
Hyderabad’s pharma players are adapting to a regulatory backlash and fighting back against dumping from China
Krishna Gopalan - March 09, 2016
"I think life sciences is the single-most important area that we can invest in"
Google Ventures' ex-managing partner Bill Maris on being at the cusp of reverse ageing
N Mahalakshmi - December 01, 2015
On safer shores
Bharuch is booming on the back of great roads, ports and a powered-up electrical grid
Krishna Gopalan - July 02, 2015
Critical condition
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat
Kripa Mahalingam - June 17, 2015